Objective/aim: To determine the incidence of steroid induced glaucoma and treatment characteristics in kidney transplant patients in a tertiary level multispecialty institution.
Methods: In this prospective cross-sectional study, the patients who underwent kidney transplant were enrolled and underwent comprehensive ophthalmological evaluation including intraocular pressure (IOP) measurement with Goldmann Applanation tonometry, visual field examination with Humphrey Field Analyzer, and gonioscopy. Cases with IOP > 21 mm Hg, visual field defect, and optic disc cupping > 0.7 or asymmetry of 0.2 or more were labeled as glaucoma, whereas IOP > 21 mm Hg with a normal visual field was designated as ocular hypertension (OHT).
Results: The mean age of patients was 39 ± 9 (range: 25-60) years. Out of 72 patients with kidney transplants, 7 (9.72%) patients were diagnosed with steroid-induced glaucoma, and 9 (12.5%) patients had ocular hypertension (OHT). Four (5.55%) patients underwent trabeculectomy to control IOP whereas 3 (4.16%) patients were controlled on anti-glaucoma medications. Best-corrected visual acuity < 6/9 was noted in 23 (31.94%) patients in at least one eye. The average follow-up was 30 months with interquartile range of 18-84 months. There was a significant association of cumulative dosage of steroid and development of cataract and OHT and glaucoma (P < 0.01).
Conclusion: Kidney transplant patients must be screened for glaucoma and other ocular abnormality and should be on routine ophthalmological follow-up due to the possibility of steroid induced glaucoma.
{"title":"Steroid-induced glaucoma in kidney transplant recipients: a prospective cross-sectional study.","authors":"Vaibhav Kumar Jain, Rachna Agarwal, Lubna Maroof, Manas Ranjan Behera, Jaya Kaushik, Sushil Ojha","doi":"10.22336/rjo.2024.66","DOIUrl":"10.22336/rjo.2024.66","url":null,"abstract":"<p><strong>Objective/aim: </strong>To determine the incidence of steroid induced glaucoma and treatment characteristics in kidney transplant patients in a tertiary level multispecialty institution.</p><p><strong>Methods: </strong>In this prospective cross-sectional study, the patients who underwent kidney transplant were enrolled and underwent comprehensive ophthalmological evaluation including intraocular pressure (IOP) measurement with Goldmann Applanation tonometry, visual field examination with Humphrey Field Analyzer, and gonioscopy. Cases with IOP > 21 mm Hg, visual field defect, and optic disc cupping > 0.7 or asymmetry of 0.2 or more were labeled as glaucoma, whereas IOP > 21 mm Hg with a normal visual field was designated as ocular hypertension (OHT).</p><p><strong>Results: </strong>The mean age of patients was 39 ± 9 (range: 25-60) years. Out of 72 patients with kidney transplants, 7 (9.72%) patients were diagnosed with steroid-induced glaucoma, and 9 (12.5%) patients had ocular hypertension (OHT). Four (5.55%) patients underwent trabeculectomy to control IOP whereas 3 (4.16%) patients were controlled on anti-glaucoma medications. Best-corrected visual acuity < 6/9 was noted in 23 (31.94%) patients in at least one eye. The average follow-up was 30 months with interquartile range of 18-84 months. There was a significant association of cumulative dosage of steroid and development of cataract and OHT and glaucoma (P < 0.01).</p><p><strong>Conclusion: </strong>Kidney transplant patients must be screened for glaucoma and other ocular abnormality and should be on routine ophthalmological follow-up due to the possibility of steroid induced glaucoma.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"362-366"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tetrachromacy and advertising: a new way of visual perception in marketing.","authors":"Consuela-Mădălina Gheorghe","doi":"10.22336/rjo.2024.63","DOIUrl":"https://doi.org/10.22336/rjo.2024.63","url":null,"abstract":"","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"341-342"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To evaluate the agreement between Spectral-Domain Optical Coherence Tomography (AS-OCT) and Oculus Keratograph® 5M in measuring tear meniscus height (TMH) and to assess the impact of contact lens wear on these measurements. Materials and methods: TMH was measured in 54 healthy eyes using AS-OCT (3D OCT-1 Maestro, Topcon, Tokyo, Japan) and Oculus Keratograph® 5M (OCULUS Optikgeräte, Wetzlar, Germany), with and without contact lens wear. Bland-Altman analysis was used to assess agreement between the two devices. Delefilcon A, water-gradient, daily disposable contact lenses were used, and measurements were carried out after a 20-minute adaptation period.
Results: The means of TMH without the contact lenses were 0.21 ± 0.06 mm and 0.20 ± 0.05 mm obtained from AS-OCT and Oculus K5M, respectively, and these measurements were not statistically significant (t (53) = 0.99, p = 0.33). No significant differences were observed in TMH compared to contact lenses (t (53) = 1.52, p = 0.13). Agreement between measurements obtained by both the instruments was assessed using Bland-Altman analysis. The limits of agreement were within clinically acceptable ranges (0.10 mm - 0.15 mm), with no evidence of significant bias (t = -0.32, r = 0.22). The results obtained with contact lenses were also not statistically significant (t (53) = 1.52, p < 0.05).
Discussion: The present study compared tear meniscus height (TMH) measurements obtained from AS-OCT and Oculus K5M in subjects with and without contact lens wear. Both instruments showed good agreement, with AS-OCT consistently measuring slightly higher TMH values than Oculus K5M. The mean TMH values were similar to those of previous studies, indicating normal tear film in the subjects. Contact lens wear was found to reduce TMH slightly, but it returned to baseline after a short adaptation period. The Bland-Altman analysis confirmed good agreement between the two instruments, with most data points falling within the limits of agreement. These findings suggest that AS-OCT and Oculus K5M can be reliable tools for measuring TMH and can be used interchangeably for clinical practice.
Conclusion: AS-OCT and Oculus Keratograph® 5M showed comparable results in measuring TMH, suggesting potential interchangeability in clinical practice. Further validation in broader clinical settings and diverse subject groups may be warranted.
{"title":"Tear meniscus height comparison between AS-OCT and Oculus Keratograph® K5M.","authors":"Angeline Lim Pei Yik, Fakhruddin Shamsheer Barodawala","doi":"10.22336/rjo.2024.72","DOIUrl":"10.22336/rjo.2024.72","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the agreement between Spectral-Domain Optical Coherence Tomography (AS-OCT) and Oculus Keratograph® 5M in measuring tear meniscus height (TMH) and to assess the impact of contact lens wear on these measurements. <b>Materials and methods</b>: TMH was measured in 54 healthy eyes using AS-OCT (3D OCT-1 Maestro, Topcon, Tokyo, Japan) and Oculus Keratograph® 5M (OCULUS Optikgeräte, Wetzlar, Germany), with and without contact lens wear. Bland-Altman analysis was used to assess agreement between the two devices. Delefilcon A, water-gradient, daily disposable contact lenses were used, and measurements were carried out after a 20-minute adaptation period.</p><p><strong>Results: </strong>The means of TMH without the contact lenses were 0.21 ± 0.06 mm and 0.20 ± 0.05 mm obtained from AS-OCT and Oculus K5M, respectively, and these measurements were not statistically significant (t (53) = 0.99, p = 0.33). No significant differences were observed in TMH compared to contact lenses (t (53) = 1.52, p = 0.13). Agreement between measurements obtained by both the instruments was assessed using Bland-Altman analysis. The limits of agreement were within clinically acceptable ranges (0.10 mm - 0.15 mm), with no evidence of significant bias (t = -0.32, r = 0.22). The results obtained with contact lenses were also not statistically significant (t (53) = 1.52, p < 0.05).</p><p><strong>Discussion: </strong>The present study compared tear meniscus height (TMH) measurements obtained from AS-OCT and Oculus K5M in subjects with and without contact lens wear. Both instruments showed good agreement, with AS-OCT consistently measuring slightly higher TMH values than Oculus K5M. The mean TMH values were similar to those of previous studies, indicating normal tear film in the subjects. Contact lens wear was found to reduce TMH slightly, but it returned to baseline after a short adaptation period. The Bland-Altman analysis confirmed good agreement between the two instruments, with most data points falling within the limits of agreement. These findings suggest that AS-OCT and Oculus K5M can be reliable tools for measuring TMH and can be used interchangeably for clinical practice.</p><p><strong>Conclusion: </strong>AS-OCT and Oculus Keratograph® 5M showed comparable results in measuring TMH, suggesting potential interchangeability in clinical practice. Further validation in broader clinical settings and diverse subject groups may be warranted.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"398-403"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tugce Horozoglu Ceran, Mehmet Citirik, Mehmet Yasin Teke
Purpose: This study examined patients with permanent legal blindness in one eye after a previous eye surgery and those with permanent legal blindness in one eye for non-surgical reasons. The objective of this study was to assess the occurrence of complications both during and after surgery in patients undergoing phacoemulsification for cataracts or vitreoretinal surgery for retinal detachment in the fellow eye.
Methods: A retrospective study included 62 patients (group 1) with legal blindness in one eye, compared to 62 control patients (group 2) undergoing similar surgeries. Complications, history of complex surgery leading to legal blindness, and demographic characteristics were analyzed.
Results: In group 1, the complication rate was significantly higher in patients who underwent both phacoemulsification and vitreoretinal surgeries than in group 2 (p < 0.05). In group 1, complications developed during surgery in the other eye in 28.1% of the patients whose permanent legal blindness stemmed from a complication in the previous surgery. In contrast, complications arose in the surgery of the other eye in 10% of patients whose permanent legal blindness did not result from any complications in the previous surgery. A statistically significant difference was observed between the two groups (P < 0.05).
Discussion: In our study, if the cause of eye loss in patients with permanent legal blindness in one eye was a surgical complication, the possibility of complications during surgery in the other eye was high. Surgery can be planned at higher visual acuity levels in a patient who has lost one eye for reasons other than surgery. In patients who have lost one eye due to previous surgery, surgery for the other can be planned at lower visual acuity levels.
Conclusion: This is the first report to compare the rate of complications during and after surgery in patients with pre-existing permanent legal blindness in one eye who underwent cataract surgery and vitreoretinal surgery in the other.
{"title":"Risk of complications in patients with one eye during and after ocular surgery.","authors":"Tugce Horozoglu Ceran, Mehmet Citirik, Mehmet Yasin Teke","doi":"10.22336/rjo.2024.74","DOIUrl":"10.22336/rjo.2024.74","url":null,"abstract":"<p><strong>Purpose: </strong>This study examined patients with permanent legal blindness in one eye after a previous eye surgery and those with permanent legal blindness in one eye for non-surgical reasons. The objective of this study was to assess the occurrence of complications both during and after surgery in patients undergoing phacoemulsification for cataracts or vitreoretinal surgery for retinal detachment in the fellow eye.</p><p><strong>Methods: </strong>A retrospective study included 62 patients (group 1) with legal blindness in one eye, compared to 62 control patients (group 2) undergoing similar surgeries. Complications, history of complex surgery leading to legal blindness, and demographic characteristics were analyzed.</p><p><strong>Results: </strong>In group 1, the complication rate was significantly higher in patients who underwent both phacoemulsification and vitreoretinal surgeries than in group 2 (p < 0.05). In group 1, complications developed during surgery in the other eye in 28.1% of the patients whose permanent legal blindness stemmed from a complication in the previous surgery. In contrast, complications arose in the surgery of the other eye in 10% of patients whose permanent legal blindness did not result from any complications in the previous surgery. A statistically significant difference was observed between the two groups (P < 0.05).</p><p><strong>Discussion: </strong>In our study, if the cause of eye loss in patients with permanent legal blindness in one eye was a surgical complication, the possibility of complications during surgery in the other eye was high. Surgery can be planned at higher visual acuity levels in a patient who has lost one eye for reasons other than surgery. In patients who have lost one eye due to previous surgery, surgery for the other can be planned at lower visual acuity levels.</p><p><strong>Conclusion: </strong>This is the first report to compare the rate of complications during and after surgery in patients with pre-existing permanent legal blindness in one eye who underwent cataract surgery and vitreoretinal surgery in the other.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"409-414"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mary Stephen, Nirupama Kasturi, Jayasri Periyandavan, Arun Sahi
Cataract is the leading cause of treatable blindness worldwide, and cataract surgery complications leading to blindness are a common cause of preventable blindness. All surgeons aim to obtain a good pupil dilation intra-operatively to ease the surgery. The small pupil is often challenging and contributes to intra and post-operative complications. Phacoemulsification, though, has many options to tackle small pupil. The same options cannot be employed in small incision cataract surgery, especially using mechanical pupil expanders. Small incision cataract surgery is very commonly performed in developing countries. The authors describe a case series of small pupil cataracts managed successfully without the use of any secondary aids to cause pupil dilatation and explain the techniques employed to manage small pupil while performing Small incision cataract surgery. With correct techniques, operative complications of small pupil can be minimized, and small incision cataract surgery is still a helpful option, especially in resource-limited settings, to provide an excellent visual recovery.
{"title":"A case series on minor incision cataract surgery in small pupil without any aids.","authors":"Mary Stephen, Nirupama Kasturi, Jayasri Periyandavan, Arun Sahi","doi":"10.22336/rjo.2024.65","DOIUrl":"10.22336/rjo.2024.65","url":null,"abstract":"<p><p>Cataract is the leading cause of treatable blindness worldwide, and cataract surgery complications leading to blindness are a common cause of preventable blindness. All surgeons aim to obtain a good pupil dilation intra-operatively to ease the surgery. The small pupil is often challenging and contributes to intra and post-operative complications. Phacoemulsification, though, has many options to tackle small pupil. The same options cannot be employed in small incision cataract surgery, especially using mechanical pupil expanders. Small incision cataract surgery is very commonly performed in developing countries. The authors describe a case series of small pupil cataracts managed successfully without the use of any secondary aids to cause pupil dilatation and explain the techniques employed to manage small pupil while performing Small incision cataract surgery. With correct techniques, operative complications of small pupil can be minimized, and small incision cataract surgery is still a helpful option, especially in resource-limited settings, to provide an excellent visual recovery.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"349-361"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We report a problematic case of solitary fibrous tumor of the orbit in an anemic patient who presented with painless, progressive outward protrusion of the right eye. Magnetic resonance imaging (MRI) orbit and brain with contrast showed a well-defined intraconal lesion in the superomedial aspect of the right orbit. The lesion was excised using a vertical eyelid split orbitotomy with minimal blood loss. Histopathological and immunohistochemical examination showed the features of a solitary fibrous tumor. This case highlighted that with careful surgical planning, total removal of a large vascular tumor could be done with less bleeding, especially in an anemic patient in whom an iota of hemorrhage was life-threatening.
{"title":"A challenging case of solitary fibrous tumor of the orbit in an anemic patient.","authors":"Sonali Vinay Kumar, Manoj Gopal Madakshira, Vinay Kumar, Alok Sati, Natasha Vinay Kumar, Sandeepan Bandopadhyay","doi":"10.22336/rjo.2024.82","DOIUrl":"10.22336/rjo.2024.82","url":null,"abstract":"<p><p>We report a problematic case of solitary fibrous tumor of the orbit in an anemic patient who presented with painless, progressive outward protrusion of the right eye. Magnetic resonance imaging (MRI) orbit and brain with contrast showed a well-defined intraconal lesion in the superomedial aspect of the right orbit. The lesion was excised using a vertical eyelid split orbitotomy with minimal blood loss. Histopathological and immunohistochemical examination showed the features of a solitary fibrous tumor. This case highlighted that with careful surgical planning, total removal of a large vascular tumor could be done with less bleeding, especially in an anemic patient in whom an iota of hemorrhage was life-threatening.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"457-461"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David-Ionuț Beuran, Camelia Constantin, Răzvan Constantin Șerban, Lucian George Eftimie, Cătălin Cornăcel
Objective: Present the diagnosis and therapeutic approach in a patient with pseudoxanthoma elasticum and ocular involvement.
Case report: A 46-year-old patient presented for progressive loss of vision and metamorphopsias in the left eye. The ophthalmological examination showed angioid streaks and secondary choroidal neovascularization. The dermatologist performed an incisional biopsy of a skin area in the right axilla that showed white-yellow, discrete streaks. Histopathological examination confirmed the diagnosis of pseudoxanthoma elasticum. It was decided to start intravitreal injections with aflibercept. Three injections were made in the left eye with subsequent visual acuity improvement.
Discussion: Angioid streaks are a rare retinal condition, and pseudoxanthoma elasticum is the most common association. Other systemic conditions are Ehlers-Danlos syndrome, Paget's disease, and hemoglobinopathies. Definite diagnosis requires skin lesions or calcified elastic fibers on pathological examination and angioid streaks of the retina. Choroidal neovascularization is a frequent complication and leads to vision loss. Intravitreal inhibitors of vascular endothelial growth factor are currently the first line of treatment.
Conclusions: Pseudoxanthoma elasticum has numerous systemic manifestations and requires a multidisciplinary team to be monitored and treated.
{"title":"Choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: case report.","authors":"David-Ionuț Beuran, Camelia Constantin, Răzvan Constantin Șerban, Lucian George Eftimie, Cătălin Cornăcel","doi":"10.22336/rjo.2024.85","DOIUrl":"10.22336/rjo.2024.85","url":null,"abstract":"<p><strong>Objective: </strong>Present the diagnosis and therapeutic approach in a patient with pseudoxanthoma elasticum and ocular involvement.</p><p><strong>Case report: </strong>A 46-year-old patient presented for progressive loss of vision and metamorphopsias in the left eye. The ophthalmological examination showed angioid streaks and secondary choroidal neovascularization. The dermatologist performed an incisional biopsy of a skin area in the right axilla that showed white-yellow, discrete streaks. Histopathological examination confirmed the diagnosis of pseudoxanthoma elasticum. It was decided to start intravitreal injections with aflibercept. Three injections were made in the left eye with subsequent visual acuity improvement.</p><p><strong>Discussion: </strong>Angioid streaks are a rare retinal condition, and pseudoxanthoma elasticum is the most common association. Other systemic conditions are Ehlers-Danlos syndrome, Paget's disease, and hemoglobinopathies. Definite diagnosis requires skin lesions or calcified elastic fibers on pathological examination and angioid streaks of the retina. Choroidal neovascularization is a frequent complication and leads to vision loss. Intravitreal inhibitors of vascular endothelial growth factor are currently the first line of treatment.</p><p><strong>Conclusions: </strong>Pseudoxanthoma elasticum has numerous systemic manifestations and requires a multidisciplinary team to be monitored and treated.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"470-475"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cerebral imaging should also be performed to examine the visual pathways of people with diabetes using visually evoked potentials.","authors":"Josef Finsterer","doi":"10.22336/rjo.2024.86","DOIUrl":"10.22336/rjo.2024.86","url":null,"abstract":"","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"476-477"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alina-Cristina Chiraples, Diana Maria Darabus, Horia Tudor Stanca, Mihnea Munteanu
Purpose: Accelerated Collagen Crosslinking (A-CXL) is widely used worldwide as an effective treatment for keratoconus due to its efficiency and rapidity. This paper aims to identify relevant changes in visual acuity parameters and topographic measurements before and six months after treatment.
Methods: A total of 30 eyes from 20 patients who underwent A-CXL between May 2021 and June 2023 and had at least six months of follow-up were analyzed retrospectively. Comparisons between uncorrected visual acuity, best corrected visual acuity, spherical and cylinder diopters, and topographic measurements like Kmax, SIf, SIb, KVf, KVb, BCVf, BCVb, TCT, and CCT were made before and six months after surgery.
Results: After the accelerated Collagen crosslinking (A-CXL), BCVA improved, cylinder diopters and Kmax values were reduced, and central corneal thickness (CCT) and thinnest corneal thickness (TCT) were elevated.
Discussion: The study has shown results comparable with other studies regarding the heterogeneity of the group study, good outcomes in measuring the corneal central thickness and thinnest corneal thickness, and good evolution of the refraction and visual acuity. Regarding the specific topography markers, like SIf/SIb, KVf/KVb, BCVf/BCVb, and Kmax, minor differences were observed at 6 months follow-up and were not considered statistically relevant. Other studies show a better correlation at 1-year check-ups and similar results at 6-month follow-ups.
Conclusion: This method's main benefits are its brief duration and minimum intrusion, improvement of visual acuity, and the possibility of reintervention for better outcomes.
{"title":"A 6-month follow-up for patients who underwent Accelerated Epi-on Collagen Crosslinking.","authors":"Alina-Cristina Chiraples, Diana Maria Darabus, Horia Tudor Stanca, Mihnea Munteanu","doi":"10.22336/rjo.2024.77","DOIUrl":"10.22336/rjo.2024.77","url":null,"abstract":"<p><strong>Purpose: </strong>Accelerated Collagen Crosslinking (A-CXL) is widely used worldwide as an effective treatment for keratoconus due to its efficiency and rapidity. This paper aims to identify relevant changes in visual acuity parameters and topographic measurements before and six months after treatment.</p><p><strong>Methods: </strong>A total of 30 eyes from 20 patients who underwent A-CXL between May 2021 and June 2023 and had at least six months of follow-up were analyzed retrospectively. Comparisons between uncorrected visual acuity, best corrected visual acuity, spherical and cylinder diopters, and topographic measurements like Kmax, SIf, SIb, KVf, KVb, BCVf, BCVb, TCT, and CCT were made before and six months after surgery.</p><p><strong>Results: </strong>After the accelerated Collagen crosslinking (A-CXL), BCVA improved, cylinder diopters and Kmax values were reduced, and central corneal thickness (CCT) and thinnest corneal thickness (TCT) were elevated.</p><p><strong>Discussion: </strong>The study has shown results comparable with other studies regarding the heterogeneity of the group study, good outcomes in measuring the corneal central thickness and thinnest corneal thickness, and good evolution of the refraction and visual acuity. Regarding the specific topography markers, like SIf/SIb, KVf/KVb, BCVf/BCVb, and K<sub>max</sub>, minor differences were observed at 6 months follow-up and were not considered statistically relevant. Other studies show a better correlation at 1-year check-ups and similar results at 6-month follow-ups.</p><p><strong>Conclusion: </strong>This method's main benefits are its brief duration and minimum intrusion, improvement of visual acuity, and the possibility of reintervention for better outcomes.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"427-433"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sangaraju Suneel, Subashini Kaliaperumal, Sunitha Kodidela, Alladi Charanraj Goud, Mary Stephen
<p><strong>Purpose: </strong>To study the ocular biometric parameters in PACD patients and to compare them with normal control subjects. To identify the role of genetic polymorphisms in PCMTD1 and COL11A1 genes in our population in PACD pathogenesis.</p><p><strong>Materials and methods: </strong>This cross-sectional comparative study included patients with PACD age-matched normal subjects. Patients who underwent prior laser iridotomy or intraocular surgery and those using miotics were excluded from the study. The comprehensive ophthalmological evaluation included slit lamp biomicroscopy, applanation tonometry, gonioscopy, and optic disc evaluation. PACD patients were classified as per the International Society for Geographical and Epidemiological Ophthalmology (ISGEO) classification into PACS, PAC, and PACG. Ocular biometry was performed for parameters like AXL, ACD, lens thickness (LT), central corneal thickness (CCT), and mean keratometry (K) values using the Partial Coherence Interferometry biometer. Variables like relative lens position (RLP) and lens axial length factor (LAF) were calculated from the above parameters. Genotyping was done for PACD patients and control subjects to look for PCMTD1, NM_001286783.1:c.215G>A and COL11A1, NM_080629.2:c.2386C>G genetic polymorphism.</p><p><strong>Results: </strong>A total of 200 eyes of 100 PACD patients and the same number of control subjects were included in the study. PACD patients had significantly shorter AXL (21.68 mm vs. 23.25 ± 0.63 in controls, p < 0.05), short anterior chamber depth (2.33 ± 0.5 mm vs. 2.97 ± 0.92, p < 0.05), and increased Lens thickness (4.45 ± 0.41 mm vs. 4.11 ± 0.45 mm, p = 0.00). The Relative lens position (2.10 ± 0.2 vs. 2.16 ± 0.17, p < 0.03), Lens axial length factor (2.06 ± 0.21 vs. 1.76 ± 0.2, p = 0.00), Mean keratometry (D) (45.73 ± 1.64 vs. 44.33 ± 1.37, p = 0.00) were significantly different. Central corneal thickness (µ) (516.15 ± 34 vs. 511.9 ± 35.28, p = 0.8) was insignificant. Among the subgroups of PACD, PACG patients had steeper corneas when compared to PACS and PAC (46.67 ± 2.45 vs. 45.55 ± 1.54 vs. 45.64 ± 1.1, p < 0.01), while other parameters were not significant. Genotyping of PCMTD1, NM_001286783.1:c.215C>T, and COL11A1, NM_080629.2:c.2386C>G polymorphism yielded no significant association with PACD.</p><p><strong>Discussion: </strong>Though association studies have identified several candidate genes, these are either not extended to other populations or controversial. In our research, ocular biometric parameters vary in primary angle closure disease patients, with corneal curvature being the only exemption in the studied variable without significant differences. We also found that the allelic frequency for PCMTD1, NM_001286783.1:c.215C>T was 95.75% and 4.25% for C and T, respectively, which is different from available data (97% and 3% for C and T in South Asians). For COL11A1, NM_080629.2:c.2386C>G, we found a % allelic frequency of 96% and 4% for C
{"title":"Ocular Biometry and Genomic Association in Primary Angle Closure Disease. A Descriptive study.","authors":"Sangaraju Suneel, Subashini Kaliaperumal, Sunitha Kodidela, Alladi Charanraj Goud, Mary Stephen","doi":"10.22336/rjo.2024.75","DOIUrl":"10.22336/rjo.2024.75","url":null,"abstract":"<p><strong>Purpose: </strong>To study the ocular biometric parameters in PACD patients and to compare them with normal control subjects. To identify the role of genetic polymorphisms in PCMTD1 and COL11A1 genes in our population in PACD pathogenesis.</p><p><strong>Materials and methods: </strong>This cross-sectional comparative study included patients with PACD age-matched normal subjects. Patients who underwent prior laser iridotomy or intraocular surgery and those using miotics were excluded from the study. The comprehensive ophthalmological evaluation included slit lamp biomicroscopy, applanation tonometry, gonioscopy, and optic disc evaluation. PACD patients were classified as per the International Society for Geographical and Epidemiological Ophthalmology (ISGEO) classification into PACS, PAC, and PACG. Ocular biometry was performed for parameters like AXL, ACD, lens thickness (LT), central corneal thickness (CCT), and mean keratometry (K) values using the Partial Coherence Interferometry biometer. Variables like relative lens position (RLP) and lens axial length factor (LAF) were calculated from the above parameters. Genotyping was done for PACD patients and control subjects to look for PCMTD1, NM_001286783.1:c.215G>A and COL11A1, NM_080629.2:c.2386C>G genetic polymorphism.</p><p><strong>Results: </strong>A total of 200 eyes of 100 PACD patients and the same number of control subjects were included in the study. PACD patients had significantly shorter AXL (21.68 mm vs. 23.25 ± 0.63 in controls, p < 0.05), short anterior chamber depth (2.33 ± 0.5 mm vs. 2.97 ± 0.92, p < 0.05), and increased Lens thickness (4.45 ± 0.41 mm vs. 4.11 ± 0.45 mm, p = 0.00). The Relative lens position (2.10 ± 0.2 vs. 2.16 ± 0.17, p < 0.03), Lens axial length factor (2.06 ± 0.21 vs. 1.76 ± 0.2, p = 0.00), Mean keratometry (D) (45.73 ± 1.64 vs. 44.33 ± 1.37, p = 0.00) were significantly different. Central corneal thickness (µ) (516.15 ± 34 vs. 511.9 ± 35.28, p = 0.8) was insignificant. Among the subgroups of PACD, PACG patients had steeper corneas when compared to PACS and PAC (46.67 ± 2.45 vs. 45.55 ± 1.54 vs. 45.64 ± 1.1, p < 0.01), while other parameters were not significant. Genotyping of PCMTD1, NM_001286783.1:c.215C>T, and COL11A1, NM_080629.2:c.2386C>G polymorphism yielded no significant association with PACD.</p><p><strong>Discussion: </strong>Though association studies have identified several candidate genes, these are either not extended to other populations or controversial. In our research, ocular biometric parameters vary in primary angle closure disease patients, with corneal curvature being the only exemption in the studied variable without significant differences. We also found that the allelic frequency for PCMTD1, NM_001286783.1:c.215C>T was 95.75% and 4.25% for C and T, respectively, which is different from available data (97% and 3% for C and T in South Asians). For COL11A1, NM_080629.2:c.2386C>G, we found a % allelic frequency of 96% and 4% for C","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 4","pages":"415-420"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}